Please wait while the formulary information is being retrieved.
BRONKAID DUAL ACTION (EPHEDRINE SULFATE/GUAIFENESIN)
25 mg-400 mg tablet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
BRONKAID DUAL ACTION (EPHEDRINE SULFATE/GUAIFENESIN)
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Ephedrine
- Severity Level:
2
- Additional Notes: Case reports of potential newborn metabolic acidosis after maternal exposure
Guaifenesin
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Ephedrine
Cardiovascular-Elderly are more sensitive to cardiovascular effects. Neuro/Psych-Risk of insomnia, confusion. Elderly may have increased sensitivity to CNS effects. Renal-May need to adjust dose with decreased renal function. Urogenital- Risk for urinary retention. Caution with prostatic hypertrophy.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool